If you are in distress, you can call or text 988 at any time. If it is an emergency, call 9-1-1 or go to your local emergency department.

National Guidance for AI in Mental Health and Substance Use Health Care

In a first-of-its-kind initiative, national guidance for using artificial intelligence (AI) in the mental and substance use health (MHSUH) field is being developed through a partnership between the Mental Health Commission of Canada and the Canadian Centre on Substance Use and Addiction.

AI is increasingly being used for healthcare triage, service navigation, service delivery, and communication, but service providers, developers and users have no guidelines specific to mental or substance use health to support its effective and safe use. The recently published E-Mental Health Strategy for Canada highlights the need for safety in this field.  

The new National Guidance for Artificial Intelligence Use in Mental Health and Substance Use Health Care will provide guidance, tools, and resources to help practitioners, organizations, and health leaders in efficiently evaluating and implementing AI-enabled mental health and substance use health care services and solutions.  

It will also support people with lived or living experience of mental health or substance use health concerns in making informed choices about these technologies, while helping technology companies design and improve such solutions to meet the needs of those who use them. The full guidance will launch in 2026. 

Our Findings

Through our literature review and environmental scan, we identified 10 key considerations for early guidance, along three main themes: trust and explainability of AI systems, human-centred care, and equity and data governance. We will refine these findings through engagement with expert advisory groups to ensure the final guidance reflects the unique considerations within the MHSUH sectors.  

By investing early in national guidance, Canada is positioning itself as a global leader in ensuring that technological innovation in healthcare translates into safer, more equitable outcomes. 

Steering Committee Members

Dr. Allison Crawford, MD, PhD

  • Chief Medical Officer, 9-8-8 Suicide Crisis Helpline
  • Professor Departments of Psychiatry and Dalla Lana School of Public Health, University of Toronto
  • Psychiatrist, Centre for Addiction and Mental Health

Dr. Ben Rosen

  • Psychiatrist, (Physician Lead, Psychiatry Emergency Services), Sinai Health
  • Medical Head, Psychiatry Partnerships with Northern Communities, Centre for Addiction and Mental Health
  • Associate Professor, Faculty of Medicine, Department of Psychiatry, University of Toronto

Carly Straker

  • Manager, System Quality and Integration, Mental Wellness and Addictions Recovery Division, Government of the Northwest Territories

Dr. Christopher DiCarlo

  • Principal/Founder, Critical Thinking Solutions

Dr. David Martell

  • Physician Lead, Addiction Medicine – Mental Health & Addictions Program, Nova Scotia Health

Dr. Gillian Strudwick

  • Scientific Director, Registered Nurse, Centre for Addiction and Mental Health

Jeannie Borg RN, MA Leadership

  • Director of Clinical Informatics and Digital Health, Waypoint Centre for Mental Health Care

Jonathan Morris

  • CEO, Canadian Mental Health Association BC Division

Rebecca Jesseman

  • Executive Director, Mental Health and Addictions, Health PEI

Russell Greiner

  • Professor, Department of Computing Science, University of Alberta
  • Adjunct Professor, Department of Psychiatry, University of Alberta
  • Canada CIFAR AI Chair and Fellow-in-Residence, Alberta Machine Intelligence Institute (Amii)

Valerie Pisano

  • President & CEO, MILA

Dr. Aislin R. Mushquash

  • Associate Professor; Lakehead University Research Chair in Youth Mental Health; Clinical Psychologist, Lakehead University  

Al Raimundo

  • Person with lived experience/Technical experience  

Anthony Esposti

  • CEO, CAPSA 

Ashley Silversides

  • Treatment Manager 
    Mamisarvik Healing Centre

Chris Cull

  • Strategic and Technical Advisory Group on Mental Health, Neurological and Substance Use Conditions
    World Health Organization 

Dr. David Wiljer, PhD

  • Associate Dean, CPD, Temerty Faculty of Medicine;
    Professor (status only), Department of Psychiatry and IHPME,
    University of Toronto; Scientist, The Wilson Centre;
    Executive Director, Education Technology Innovation, 
    University Health Network.

Jason Miller

  • Person with Lived Experience and Technical Experience

Dr. Leslie E. Roos

    • Associate Professor, Departments of Psychology & Pediatrics; Licensed Clinical Psychologist; Clinical Scientist at Children’s Hospital Research Institute of Manitoba; CIHR Implementation Science Chair in Human Development, Child, and Youth Health

      The University of Manitoba

Norm Odjick

  • Director General, Algonquin Anishinabeg Nation Tribal Council 50

Sign up for updates on this project

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form